WebNov 18, 2024 · Shares of clinical-stage, oncology-focused biopharmaceutical company CytomX Therapeutics, Inc.(CTMX Quick Quote CTMX - Free Report) skyrocketed 32.2% after the company announced a collaboration ... WebApr 13, 2024 · CytomX Therapeutics currently has a consensus price target of $3.17, indicating a potential upside of 94.57%. Stoke Therapeutics has a consensus price target of $24.57, indicating a potential upside of 205.61%.
CTMX CytomX Therapeutics Inc. Stock Price & News - WSJ
WebCTMX Stock 12 Months Forecast $2.48 (64.24% Upside) Based on 4 Wall Street analysts offering 12 month price targets for CytomX Therapeutics in the last 3 months. The average price target is $2.48 with a high forecast of $3.20 and a low forecast of $2.00. The average price target represents a 64.24% change from the last price of $1.51. WebApr 14, 2024 · The stock has a fifty day moving average price of $2.01 and a 200-day moving average price of $1.84. ... Receive News & Ratings for CytomX Therapeutics … lithuania and china
CTMX CytomX Therapeutics Inc. Stock Overview (U.S.: Nasdaq)
WebCTMX Key Statistics Market cap 100.34M Price-Earnings ratio -1.21 Dividend yield — Average volume 1.36M High today $1.53 Low today $1.46 Open price $1.46 Volume … WebJan 26, 2024 · SOUTH SAN FRANCISCO, Calif., Jan. 26, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused bioph... WebApr 10, 2024 · 11 Wall Street research analysts have issued 12-month target prices for CytomX Therapeutics' shares. Their CTMX share price forecasts range from $1.50 to $8.00. On average, they anticipate the … lithuania and latvia map